NCPA March 17, 2021
ALEXANDRIA, Va. (March 17, 2021) The National Community Pharmacists Association is pleased to announce that McCoy-Tygart Drug in Sheridan, Ark., has earned the 2021 NCPA Innovation Center Excellence Award for Best COVID-19 External Modification. This is the fourth year of the NICE Awards competition, which was created to recognize pharmacies for their efforts to enhance their value, promote their services, and better serve their communities. The NICE Awards are sponsored by QS/1.
“Congratulations to McCoy-Tygart Drug for earning the NICE Award for Best COVID-19 External Modification,” said Kurt Proctor, PhD, RPh, president of the NCPA Innovation Center. “The NICE Awards spotlight the best of community pharmacy branding and marketing – the innovations and redesigns that have made promotions more effective and patients’ experiences more rewarding. When it became clear that the coronavirus would change the world as